HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public

Abstract

This study aims to establish the value evaluation framework based on multi-criteria decision analysis for orphan drugs in China from the perspectives of stakeholders and the public, so as to provide evidence for the decision-making of medical insurance access.